Inventor · disambiguated record
David Lee Tamang
Also filed as: TAMANG DAVID LEE
4 granted patents·5 pending applications·33 citations·filing 2014–2023
74Inventor score
Files withACETYLON PHARMACEUTICALS INC9
Top patents by PatentIndex Score
9 records- 0190US9278963B2Pyrimidine hydroxy amide compounds as histone deacetylase inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2014·Granted Mar 8, 2016·17 cites·24 claims
- 0286US9403779B2Combinations of histone deacetylase inhibitors and either Her2 inhibitors or PI3K inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2014·Granted Aug 2, 2016·10 cites·4 claims
- 0380US9833466B2Treatment of leukemia with histone deacetylase inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2015·Granted Dec 5, 2017·5 cites·10 claims
- 0476US10722512B2Combinations of histone deacetylase inhibitors and either HER2 inhibitors or PI3K inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2016·Granted Jul 28, 2020·1 cites·6 claims
- 0574US2023364083A1Histone deacetylase 6 (hdac6) biomarkers in multiple myelomaACETYLON PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0664US2020405716A1Histone deacetylase 6 (hdac6) biomarkers in multiple myelomaACETYLON PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0756US2015176076A1Histone deacetylase 6 (hdac6) biomarkers in multiple myelomaACETYLON PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 0842US2016279128A1Pyrimidine hydroxy amide compounds as histone deacetylase inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 0940US2016339022A1Treatment of neuroblastoma with histone deacetylase inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →